ETY KLINGER;YEDA RESEARCH AND DEVELOPMENT CO. LTD.
发明人:
ETY KLINGER
申请号:
IL25194317
公开号:
IL251943D0
申请日:
2017.04.26
申请国别(地区):
IL
年份:
2017
代理人:
摘要:
A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a patient who has experienced a first clinical episode and is determined to be at high risk of developing clinically definite multiple sclerosis comprising administering to the human patient three subcutaneous injections of a therapeutically effective dose of glatiramer acetate over a period of seven days with at least one day between every subcutaneous injection so as to thereby alleviate the symptom of the patient.